Cocaine Use Disorder
84
19
22
49
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
21 trials with published results (25%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
4.8%
4 terminated out of 84 trials
92.5%
+5.9% vs benchmark
4%
3 trials in Phase 3/4
43%
21 of 49 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 49 completed trials
Clinical Trials (84)
rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder
An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder
Imaging CRF X NOP Interactions in CUD
[C-11]NPA PET-amphetamine in Cocaine Use Disorders
Contingency Management for Drug Use: Does Age Matter?
Impact of Cocaine Use and Withdrawal on Sleep
Cocaine and Pentoxifylline (BED IN 47)
Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder
Low-Intensity Focused Ultrasound for Cocaine Use Disorder
Treating Polysubstance Use Using a Novel Digital Technology
Behavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine)
LDART for Stimulant Use Disorder
SXC-2023 Cocaine Interaction Study
Phase1, STP7 Cocaine Drug-Drug Interaction Study
Pioglitazone as an Adjunct to Cognitive-Behavioral Therapy for Cocaine Relapse Prevention
Repurposing Semaglutide for the Treatment of Cocaine Use Disorder
Exenatide For Reducing the Reinforcing Effects of Cocaine
Reconsolidation Blockade of Intrusive Trauma- and Cocaine-related Memories
Transcranial Direct Current Stimulation (tDCS) for Treatment of Cocaine Use Disorder
Efficacy of Clonidine in Reducing Craving in Inpatients With Cocaine and Crack Use Disorder